Knock‐down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells
- 13 December 2005
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 208 (3) , 372-380
Abstract
Hepatitis B virus (HBV) infection is a major cause of hepatocellular carcinoma (HCC) in Southeast Asia and Hong Kong. Among the four proteins that are encoded by the HBV genome, HBV X (HBx) is the most potentially oncogenic factor. It is known that HBx plays an important role in hepatocarcinogenesis, but the exact functions and molecular mechanisms of HBx in HCC are not well understood. In this study, we constructed expression vectors for small hairpin RNAs (shRNA) against HBx and investigated their regulatory effects in PLC/PRF/5 HCC cells, which constitutively produce HBx. Our data show that this tool of RNA interference (RNAi) could successfully reduce the HBx mRNA and protein levels by 50–95%. RNAi targeting HBx in PLC/PRF/5 cells demonstrated significant reduction in cell proliferation, cell growth, anchorage‐independent growth in soft agar, and tumour development in nude mice. In addition, depletion of HBx expression increased cell sensitivity to TNFα‐mediated and serum‐free‐induced apoptosis, and reduced the expression levels of C‐myc and Bcl‐XL. These findings suggest that HBx plays an important role in tumorigenicity and anti‐apoptotic mechanisms in HCC. Copyright © 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 23 references indexed in Scilit:
- c‐myc‐induced hepatocarcinogenesis in the absence of IGF‐I receptorInternational Journal of Cancer, 2004
- MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancerNature, 2004
- Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cellsBiochemical and Biophysical Research Communications, 2004
- Specific inhibition of gene expression and transactivation functions of hepatitis B virus X protein and c‐myc by small interfering RNAsFEBS Letters, 2004
- Induction of an interferon response by RNAi vectors in mammalian cellsNature Genetics, 2003
- HBV integrants of hepatocellular carcinoma cell lines contain an active enhancerOncogene, 2001
- Distinctive gene expression profiles associated with Hepatitis B virus x proteinOncogene, 2001
- Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomasHepatology, 1998
- The value of hepatitis B x antigen as a prognostic marker in the development of hepatocellular carcinomaInternational Journal of Cancer, 1993
- Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucksNature, 1986